Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Quadrise

    MCap

    GBP32m

    Last close

    GBP0.02

    ▲ 0.32 (21.62%)

    Tetragon Financial Group

    MCap

    USD1,600m

    Last close

    USD11.45

    ▲ 1.30 (12.81%)

    SenSen Networks

    MCap

    AUD46m

    Last close

    AUD0.06

    ▲ 0.00 (7.55%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

BB Biotech – executive interview

BB Biotech – executive interview

BB Biotech — 6 videos in collection

More on this equity

In this interview, we speak to Dr Christian Koch, deputy head of investment management at BB Biotech (BION), the Switzerland-based investment company listed in Switzerland, Germany and Italy. Dr Koch will assume the role of head of investment management at BB Biotech at the beginning of 2025.

Dr Koch discusses the reasons for the improvement in investor sentiment regarding the biotech sector over the past year. He provides detail on some major milestones on the horizon for BB Biotech’s holdings and explains how the team’s data scientists are using big data and AI to enhance every aspect of the investment process and provide novel insights into developments in the sector.

< Previous
Next >

You may also be interested in these:

Growth Conf thumbnail (2)

Edison Growth Conference panel – 2024: The year of M&A?

Investment Companies

BB Biotech – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free